Table 2.
Outcomes by site of recurrence and RT dose in abdominal stage II and III patients: each patient evaluated for both sites of potential recurrence.
Flank | Beyond - Flank | |||
---|---|---|---|---|
RT dose | # Evaluated | # Events (%) | # Evaluated | # Events(%) |
No RT | 105 | 13(12.4) | 292 | 18(6.2) |
10 Gy | 231 | 7(3.0) | 120 | 3(2.5) |
20 Gy | 114 | 0(0.0) | 38 | 1(2.6) |
Total | 450 | 20(4.4) | 450 | 22(4.9) |